NMDA receptor antagonists interventions in schizophrenia: Meta-analysis of randomized, placebo-controlled trials

Our results indicate that NMDAR-ANTs as adjunctive therapy may improve cognitive function in patients with schizophrenia. Because the included studies were small, a replication study using larger samples is needed.